Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001340695 | SCV001534518 | likely benign | Dilated cardiomyopathy 1DD | 2024-04-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003382536 | SCV004096533 | uncertain significance | Cardiovascular phenotype | 2023-07-20 | criteria provided, single submitter | clinical testing | The p.G758S variant (also known as c.2272G>A), located in coding exon 9 of the RBM20 gene, results from a G to A substitution at nucleotide position 2272. The glycine at codon 758 is replaced by serine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Genome Diagnostics Laboratory, |
RCV001729852 | SCV001978192 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001729852 | SCV001979473 | likely benign | not provided | no assertion criteria provided | clinical testing |